Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01A TETRACYCLINES
J01AA Tetracyclines
J01AA12 Tigecycline
D01079 Tigecycline (JAN/USP) <JP/US>
USP drug classification [BR:br08302]
Antibacterials
Antibacterials, Other
Tigecycline
D01079 Tigecycline (JAN/USP)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
61 Antibiotics
612 Acting mainly on gram-negative bacteria
6129 Others
D01079 Tigecycline (JAN/USP)
Drug groups [BR:br08330]
Antibacterial
DG01197 Tetracycline antibiotic
D01079 Tigecycline
Drug classes [BR:br08332]
Antibacterial
DG01197 Tetracycline antibiotic
D01079 Tigecycline
Antimicrobials [BR:br08307]
Antibacterials
Protein biosynthesis inhibitor
Tetracycline
D01079 Tigecycline (JAN/USP) <JP/US>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Protein biosynthesis inhibitor
Tetracycline
D01079 Tigecycline (JAN/USP)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01079
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D01079
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01079
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01079